Insmed (INSM) Misses Q3 EPS by 12c; Reports Cash and Cash Equivalents of $846.6M
Tweet
Share
E-mailGet Alerts INSM Hot Sheet
Price: $102.15 +3.59%
Revenue Growth %: +264.2%
Financial Fact:
Net loss: -37.76M
Today's EPS Names:
CRWS, MEI, PODC, More
Revenue Growth %: +264.2%
Financial Fact:
Net loss: -37.76M
Today's EPS Names:
CRWS, MEI, PODC, More
Join SI Premium – FREE
Insmed (NASDAQ: INSM) reported Q3 EPS of ($0.96), $0.12 worse than the analyst estimate of ($0.84). Revenue for the quarter came in at $46.8 million versus the consensus estimate of $50.68 million.
For earnings history and earnings-related data on Insmed (INSM) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- Worthington Industries (WOR) Misses Q4 EPS by 9c
- FedEx (FDX) Tops Q4 EPS by 39c, Beats on Revenue; Offers FY27 EPS Guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
